Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Finally, Credit Suisse Group reiterated an “outperform” rating and issued a $34.00 price objective on shares of AbCellera Biologics in a research report on Wednesday, February 22nd.
IFP Advisors Inc acquired a new position in shares of AbCellera Biologics Inc. () in the third quarter, reports.